ArticleLeukemia2025

Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma.

Tayla B Heavican-Foral et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.